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ABSTRACT
PRECONCEPTION CARE OF WOMEN ON PRESCRIBED OPIOIDS
The landmark 2015 report from the Center for Disease Control (CDC) posited that too
many women of reproductive age received prescribed opioids. This is significant because fetal
exposure to a known teratogen can have catastrophic outcomes. Furthermore, women are often
ambivalent about birth control and many pregnancies are unplanned. Fortunately, women
identify interactions with health care providers as acceptable cues for preconception decision
making. Data has shown that Medicaid populations are disproportionately prescribed opioids
compared to insured populations. However, the CDC defines reproductive status by age only.
Therefore, the purpose of this research project was to identify women’s actual risk for pregnancy
as defined by presence or absence of menopause, sterilization, or long-acting, reversible birth
control (LARC).
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CHAPTER 1: INTRODUCTION
The landmark 2015 report from the Center for Disease Control (CDC) posited that too
many women of reproductive age received prescribed opioids (Ailes et al., 2015). This is
significant because fetal exposure to a known teratogen can have catastrophic outcomes (Yazdy,
Mitchell, Tinker, Parker, & Werler, 2013). Furthermore, women are often ambivalent about
birth control and many pregnancies are unplanned (W. Mosher, Jones, & Abma, 2015).
Fortunately, women identify interactions with health care providers as acceptable cues for
preconception decision making. Data has shown that Medicaid populations are
disproportionately prescribed opioids compared to insured populations (Ailes et al., 2015).
However, the CDC defines reproductive status by age only. Therefore, the purpose of this
research project was to identify women’s actual risk for pregnancy as defined by presence or
absence of menopause, sterilization, or long-acting, reversible birth control (LARC).
Background
Fetal exposure to opioids can have catastrophic consequences. Women taking opioids
between one month before conception and two months post-conception risk miscarriage, birth
defects, stillbirth, and newborn abstinence syndrome (Yazdy et al., 2013). The authors reported
peri-conception opioid use in women correlating with a statistically significant 2.2-fold increase
in risk of neural tube defects (or a prevalence of 5.9 per 10,000 live births). Broussard et al.
(2011) revealed a statistically significant correlation between maternal opioid use and profound
congenital cardiac, spinal, and intestinal pathology. Many pregnancies are not discovered until
well after 4 weeks which greatly increases the chances of fetal exposure to opioids (Ailes et al.,
2015). Weaning a pregnant woman off opioids can result in stillbirth (fetal abstinence syndrome)
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so the standard of care is to switch her to methadone or buprenorphine and expect to wean the
newborn off opioids (Cunningham, 2005; Yazdy et al., 2013).
The literature indicates that women are often ambivalent about birth control and many
pregnancies are unplanned. Between 2006 and 2010, 37% of births in the United States were
unintended and low income and less education correlated with higher rates (D. Mosher, Jones, &
Abma, 2015). Borrero et al. (2015) found that women in one urban setting did not necessarily
perceive that they had reproductive control nor clear pregnancy intentions. The benefits of a
planned pregnancy were often not understood or valued. Women’s behavior belied their
intentions when actively seeking to avoid pregnancy. This mirrored qualitative work done in
family planning clinics in the Midwest (Askelson, Losch, Thomas, & Reynolds, 2015).
Fortunately, women identify interactions with health care providers as acceptable cues for
preconception decision making. The Health Belief Model (HBM), suggests that people will be
more likely to change their health promotion activities when they identify obstacles to change
and are prompted to have informed decision-making (Rosenstock, Strecher, & Becker, 1988).
See Table 1 for the 6 basic constructs. The Expanded Health Belief Model (EHBM) was
developed specifically to validate the Health Belief Model in the realm of preconception care of
women with chronic disease (though with diabetes rather than chronic pain syndrome)
(Charron‐Prochownik et al., 2001).
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Table 1
The six major cognitive constructs of (E)HBM.
1. Perceived susceptibility is an individual’s belief of their own vulnerability to a problem.
2. Perceived severity is their belief about the seriousness of the problem.
3. Perceived benefits are an individual’s belief that behavior change will result in a positive
outcome.
4. Perceived barriers are an individual’s belief in difficulties in implementing behavior
change associated with a positive health outcome.
5. Self-efficacy is the confidence in one’s ability to perform effective health behaviors.
6. Motivational cues represent triggers for the intention to change health behaviors.
Rich (2015)
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Consider a 35-year-old female presenting to her advanced practice registered nurse
(APRN) requesting treatment for severe sciatica. To change the patient’s health promotion
activity, the APRN can frame the interaction with the EHBM (theory from Charron-Prochownik,
2001, case study by author). The patient is using the withdrawal method for birth control. As
treatment for sciatica may include prescription of teratogenic medications (opioids and/or
tricyclics), the APRN identifies the intervention as offering LARC to the patient. The individual
perception is the patient’s perceived susceptibility to pregnancy and perception of the severity (or
serious nature) of an unplanned pregnancy (fetal withdrawal syndrome, birth defects) (Yazdy et
al., 2013). Mediating and modifying factors include psychosocial factors, a religious objection to
actively preventing pregnancy as well as motivational cues and the patient’s rapport and trust in
her APRN. Likelihood of action depends on the perceived benefits of change (initiating LARC or
sterilization or titrating off the opioids), the patient’s self-efficacy (does she defer to her husband
on matters of reproduction?), and her intent to change her birth control method. The reproductive
health behavior outcome is seeking preconception care as defined as willingness to engage in a
conversation about her birth control method.
Studies have shown that women do, in fact, find shared decision-making with providers
acceptable while provider driven or patient driven decision-making resulted in lower patient
satisfaction in the process and the method chosen (C. Dehlendorf & Steinauer, 2012; C.
Dehlendorf, Kimport, Levy, & Steinauer, 2014). The authors in both studies used the Four
Habits Model for effective and efficient office visits and “investing in the end” was especially
successful in improving the patient experience, even more so than Motivational Interviewing (C.
Dehlendorf & Steinauer, 2012).
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Behavior modification relates to both the APRN and her patient. Studies have shown
that if clinicians are not confident in their LARC knowledge and skills, they are less likely to
have high LARC adoption by their patients (C. Dehlendorf, Levy, Ruskin, & Steinauer, 2010). A
meaningful interaction with her APRN can promote healthy behavior change in the patient by
either choosing LARC or discontinuing the teratogenic medication. Furthermore, training
providers in LARC improves LARC rates (Harper et al., 2015). Evidence based preconception
care is important in chronic disease for the above reasons as well as those promoted by the
Healthy People 2020 campaign: family planning improves the lives of women and children and
permits teens and women to finish or advance their education; smaller families allow more
investment in each child, resulting in improved educational and other outcomes (CDC, 2011).
Problem statement
The CDC looked at prescription claim data between 2008 and 2012 and found Medicaid
opioid prescriptions significantly higher than private insurance opioid prescriptions in women
between 15 and 44 years of age (Ailes et al., 2015). In the author’s view, “All women who might
become pregnant are at risk” (Ailes et al, 2015, pp. 1). The authors further went on to propose
that too many women of reproductive age were receiving prescribed opioids. The 2016 CDC
Guideline for Prescribing Opioids for Chronic Pain recommends discussing contraception and
the impact of opioids on a pregnancy before starting opioid therapy in reproductive age women
(Dowell, Haegerich, & Chou, 2016). However, the author’s checklist for prescribing opioids for
chronic pain does not mention reproductive health.
The county of the population of interest has a mandate to reduce the incidence of drug
addicted newborns called Drug Free Redacted. A decade ago, nine drug addicted newborns were
reported by the county every year. Between 2012 and 2014, it was approximately 25 newborns

6
every year (reference redacted). While this reflects national and state trends, it is twice the state
average and likely due to county mandated universal screening questions for every pregnant
woman (Tolia et al., 2015). There is no state requirement to drug test newborns or mothers.
While much of this was illicit drug use, some was from diverted prescription opioids and maybe
legally prescribed opioids (Warren, 2016). This is especially pertinent in the community health
setting since the main finding of the Ailes et al (2015) research revealed that Medicaid
populations are prescribed opioids at higher rates than insured. Furthermore, 41% of the births in
the county are to women funded by MCAID (source redacted).
The Federal push for evidence based practice and opioid prescription is evidenced in their
campaign: “Treating for Two” which endorses thoughtful prescription of medication before and
during pregnancy (http://www.cdc.gov/pregnancy/meds/treatingfortwo/index.html). This is an
outgrowth of the United States’ Healthy People 2020 established family planning goal to
promote pregnancy planning and spacing, and reduce unintended pregnancies (CDC, 2011).
A physician group with attention to preconception care of the chronically ill is the
American Academy of Neurology (Fountain et al., 2015). Their Epilepsy Quality Measurement
Set includes annual counseling for women of childbearing years. This could serve as a model for
chronic pain guidelines around reproductive health. Unfortunately, their data shows that the
guidelines are not being followed diligently with less than half of seizure patients receiving
counseling on the effects of seizure medications on contraception (oral contraceptives become
less effective) and pregnancy (birth defects and pregnancy complications). Neurologists
themselves were unable to identify teratogenic medications (Fountain et al., 2015).
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Purpose of Project
The purpose of this project was to analyze data from 145 female patients between the
ages of 18 and 45 with a diagnosis of chronic pain syndrome. The research question was what
percentage of these patients have received effective preconception care? Effective preconception
care was defined not just by age but whether the woman had been prescribed LARC, was
menopausal, or if she or her partner were sterilized. The population of interest were patients at a
community health center on the West Coast of the United States of America. The institution is a
large federally qualified health center (FQHC) that uses electronic medical records from which
reproductive health data can be drawn. Overall, the FQHC patients were 51% Hispanic/Latino,
38% White, and 11% other. Eighty-two percent had incomes at or below the Federal Poverty
Level, 39% were un-insured, and 41% had Medicaid (source redacted).
Uninsured men and women in this setting have access to free birth control (including
sterilization) through the federal Title X program regardless of immigration status and LARC is
available in-house. Male sterilization is available in-house and female sterilization is referred
out: tubal ablation is same day surgery in the hospital and tubal occlusion in the gynecologist’s
office. Many of the unfunded patients are mono-lingual Spanish speaking immigrants from
Mexico who work in the agriculture or service industry.
Low income women, minorities, and the less educated have much higher rates of
pregnancies nationally (Clinical preventive services for women: Closing the gaps, 2011). Walker
et al. (2010) found that low-income older minority patients have poorer access to health care due
to higher out-of-pocket costs and transportation difficulties. The 2015 CDC report found the rate
of opioid prescriptions filled for private insurers was significantly lower than those filled for
Medicaid (Ailes et al., 2015) which replicated data from (Edlund et al., 2010).
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One of the basic assumptions of the project was that long acting reversible
contraception was the preferred choice for women on teratogenic medications. This was because
of treatment adherence. Half of pregnancies in the United States are unintended and the rates are
worse in women who are low income, minority, or less educated (Ailes et al., 2015). These
unintended pregnancies correlate with birth control methods that are user dependent. Oral
contraceptives are not very effective even when used perfectly and most women cannot
remember to take a pill every day (Likis, 2014). Condoms are even less effective and are user
dependent: incorrect use can cause them to break or slip off and they must be used for every sex
act. The injectable contraceptive Depo-Provera requires that women return to the clinic every
three months. On the other hand, while LARC requires specialized training for insertion and
removal, it’s use is not user dependent. The IUDs (3, 5, or 10 years) are as effective as surgical
sterilization and the 3-year implant almost matches that. Importantly, women do not seem to
mind this loss of control and the patient satisfaction rates are high and discontinuation rates are
low (Likis, 2014).
Health Literacy
The population of interest is mostly high school educated, older white women on
disability. This is relevant since the 2003 National Assessment of Adult Literacy found that a
lower than average health literacy correlated with living below the poverty line and lower levels
of educational achievement. Studies have also shown that lack of skills in health literacy results
in adverse outcomes because of an inability to effectively manage chronic disease and difficulty
taking medications as directed (Dickens, 2013). Hence, there is the need for birth control
methods that do not require daily action on the part of the patient (e.g. LARC and sterilization).
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On the other hand, researchers at Yale were looking at ways to increase community
level awareness and approval of long-acting contraceptives (Anonymous, 2013). This study
surveyed low income women and found that more than half were not sure that intra-uterine
devices (IUDs) were safe or effective. Almost 75% didn’t know if contraceptive implants were
safe and effective (Anonymous, 2013). This contrasts with the international data on the
popularity of LARC in developed countries outside the United States. The respondents in the
study were more interested in LARC if they had a friend with the method. The researchers
suggested social networks and peer educators as a good method for increasing community
awareness and acceptance of LARC.
Legal and Ethical Issues
The treatment of chronic pain syndrome in women of reproductive age presents the
ethical dilemma of prescribing a teratogenic medication to a woman who could become pregnant
and the legal liability of catastrophic fetal outcomes. The ethical dilemma is that the rights of the
individual demand that providers respect the patient’s request for the opioid prescription. The
rights of society demand that providers avoid exposing a fetus to opioids. The utilitarian view
(hard paternalism) supports the CDC report of too many women of reproductive age on opioids
but Kantian ethics promotes individual rights, informed consent, and patient autonomy and
supports the argument that it is ethical and legal to prescribe a woman opioids when she has a
reliable, first tier form of birth control (sterilization or LARC) (Rich, 2015). The greater good
can still be served while respecting individual legal and ethical rights through a transparent
conversation between the patient and her APRN.
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Nature of the doctoral project
The research design for this DNP capstone project was a quantitative, descriptive, nonexperimental, retrospective analysis of existing data. The Center for Disease Control (CDC)
reported that too many women of reproductive age were receiving prescribed opioids (Ailes et
al., 2015). The research question was: women of reproductive age who are receiving prescription
opioids, what percentage have received effective preconception care? Data was analyzed using
descriptive statistics.
Significance and Summary
The 2015 Ailes et al report from the CDC was a call to arms. APRN prescribers and
others have the responsibility of safe and evidence based prescribing practices (Cronenwett et al.,
2009) as well as comprehensive preconception counseling. Medicaid populations are
disproportionately prescribed opioids compared to insured populations (Ailes et al., 2015).
However, the CDC defines reproductive status by age only. This project seeks to identify
women’s actual risk for pregnancy as defined by presence or absence of menopause,
sterilization, or long-acting, reversible birth control in an underserved patient population.

CHAPTER 2: LITERATURE REVIEW
The problem addressed in this doctoral project is based on the CDC report that too many
women of reproductive age are receiving prescribed opioids (Ailes et al., 2015). The research
question is “Of women of reproductive age who are receiving prescription opioids, what
percentage have received effective preconception care in a community health setting?” In other
words, the project expands the definition of reproductive state beyond just age and sex.
Ailes et al. (2015) performed a retrospective study of opioid prescription claims in
Medicaid and insured populations from 2008 to 2012. They looked at millions of data points
from women between the ages of 15 and 44 in the United States of America. The primary goal of
this study was to determine the frequency and type of opioid prescription per patient. Descriptive
statistics and a chi-square test were used for the analysis. Results showed that opioids were
widely prescribed in women of reproductive age and there was a disparity between Medicaid and
insured populations. The strength of this study was the sheer volume and validity of its data (not
just opioids prescribed but picked up at the pharmacy) that replicated previous work. The
weakness was the definition of reproductive status based on age alone without considering
menopause, sterilization, or presence of long-acting birth control. This weakened their
recommendations for further action. See Figure 1.
Ailes et al. (2015) was a retrospective analysis of data already collected by the Truven
Health’s MarketScan Commercial Claims and Encounters and Medicaid data. This was a
convenience sample of employed persons and their families as well as Medicaid data from 13
states. Geographic data was only available for private insurance claims and showed opioid use
higher in reproductive age women in Southern United States than in the Northeast.
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Figure 1. Ailes et al. (2015)
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Ethnicity was only available for Medicaid claims which showed statistically significant higher
rates of opioid prescription among white women as compared to black or Hispanic women. This
validated previous work.
Askelson et al. (2015) published a qualitative study of 28 women (20-45 years of age)
recruited via flyers in family planning clinics. Structured in-person and phone interviews done in
2012 in a rural mid-west state explored themes of ambivalence about unplanned pregnancy. Live
coders, NVivo10 software, and the Braun and Clark process were used. The outcome showed
that the women had both positive and negative feelings about pregnancy. Previous research had
only revealed negative feelings. The authors elicited rich content from the participants but did
not note if saturation was reached. Also, patients were prompted about having positive or
negative feelings and the findings might not be applicable to more diverse, urban populations.
Broussard et al. (2011) performed a population-based case controlled study of infants
from a national database (with birth defects versus without). A correlation was sought between
unexplained birth defects (the outcome) and maternal prescription of opioids from 1 month
preconception until the end of the third trimester. This was a very large, vigorous study including
very specific correlations with distinct types of birth defects (more than 17,000 case mothers and
6,000 control mothers). However, the n for some birth defects was too small for strong statistical
analysis. Demographics were collected so that the odds ratios could be adjusted. Mothers came
from 10 states in the United States (West, East, and South) with most having not graduated from
high school (82.2 %). Most were women between 20 and 40 years of age with 10.9% under 20
years and only 2.9% over 40 years. Ethnicity was 60% white and 23.2% Hispanic (black and
other making up the rest) (Broussard et al., 2011). Multi-variable logistic regression analysis was
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used to calculate the odds ratio and confirmed an association between opioid exposure and
congenital heart defects.
Charron‐Prochownik et al. (2001) conducted a multi-site, exploratory, case-controlled
study of 80 female teens in diabetes clinics in Pennsylvania, New England, and the Midwest.
Teens were reimbursed $10 for completing a one hour phone interview examining their health
care beliefs. Multi-linear regression and binary logistical regression of variables found that
several major constructs of the expanded health belief model (EHBM) strongly correlated with
behaviors and metabolic control (self-reported). Age was 16 to 20 years, most in school and
coming from households with high school completion or higher. Most households had an income
of $20,000 or higher and the girls/women were insured 76.3% by private insurance and only
8.8% Medicaid (Charron‐Prochownik et al., 2001). This validated previous work using EHBM
but may not be applicable to other populations.
Christine Dehlendorf et al. (2014) used grounded theory techniques to examine the
interaction between female patients and health care providers providing contraceptive counseling
in family planning, primary care, and gynecology offices. They randomly chose and analyzed 50
interactions from a larger sample of 342 audio-recordings between 2009 and 2012 in the same
region as the doctoral project. Live and computer-aided transcription (Atlas.ti) were utilized,
reliability was determined by multiple coders, and thematic saturation was reached. The
population was diverse but did not report whether the patients found their sessions helpful. Most
patients had incomes at lower than 200% the national poverty rate (68%) and the birth control
was covered by either publicly funded programs or private insurance. Most had education
beyond high school (70%). The providers were all female and between 35-74 years and most
were white (60%) (C. Dehlendorf et al., 2014). Three common styles of counseling approaches
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were found: little discussion and method chosen by provider, informed choice, and shared
decision making.
Harper et al. (2015) conducted a cluster randomized trial of long-acting reversible
contraceptive use in 40 Planned Parenthood clinics in the Eastern United States (Pennsylvania).
The outcomes were choice of IUD or implant as well as the pregnancy rates of 1500 women
aged 18-25 years between 2011-2013. Generalized estimating equations were used for clustered
data and survival analysis for the pregnancy rates. A large n and cluster format improved
reliability and validity of results but the study may not be reproducible to other settings or
provider types. This study was part of the Contraceptive CHOICE Program. Insurance of the
patients was 30% private and 27.5% Medicaid with most having obtained a high school diploma
or lower (73%). Ethnicity was 49.6% white, 27.2% Latina, and 14.8% black (Harper et al.,
2015). The results were that pregnancy rates were reduced among patients whose providers
(physicians/APRNs/PAs) received the intervention of extra training in LARC. This validated
previous research.
The National Survey on Family Growth used data from >9000 women (15-44 years)
sampled during the year 2002 and between 2006 and 2010 (W. Mosher et al., 2015). Their
research sought to identify factors associated with non-use of contraception by women at risk of
pregnancy using logistical regression analysis. The top three reasons for not using contraception
were: not believing she could get pregnant, not minding becoming pregnant, and not planning on
sexual intercourse. Fifty percent of Hispanic vs 29% of Black women cited the first reason which
confirmed qualitative work (Borrero et al., 2015). Most of the women sampled had incomes
below 300% of the national poverty rate. Fourteen percent were funded with private insurance
and other or no insurance 40%. The researchers found that women 35 and older were less likely
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to be using a method than between 20 – 34 years of age and the rate of non-use vs education
level (low to high) was curvilinear.
Steinkellner (2010) examined retrospectively prescription medication claims for oral
contraceptive pills (OCPs) in almost 500,000 American women 18-44 years of age. The outcome
measured was compliance with OCPs with or without concurrent prescription of a category X
medication. Multi-variable logistical regression was used to identify factors associated with
adherence. Co-prescription of a category X medication did not positively correlate with
compliance with OCPs. This study had a large n with reliable and valid data but did not include
any correlation with health outcomes. Lower adherence was associated with income below
$20,000 a year, identifying as an ethnic minority, younger age, and less education. The data was
taken from Medco Health Solutions in New Jersey but it was not clear the geographic
demographics of the study participants. Furthermore, adherence to oral contraceptive regime
varied from medication class to class and opioids were not specifically separated out
(Steinkellner, 2010).
Yazdy et al. (2013) analyzed data from the Slone Epidemiology Center Birth Defects
Study to answer the question: is maternal opioid use before and during pregnancy associated
with neural tube defects such as spina bifida. It was an on-going, case controlled study utilizing
telephone interviews of more than 20,000 mothers of non-malformed and malformed offspring
from 1998-2010. The data was taken from urban hospitals in Massachusetts, New York, Canada
(Toronto), and California. Of the neural tube cases, 59.7% were white, 19.7% Hispanic, and
11.5% black. Logistic regression models were used to estimate odds ratios. A statistically
significant higher percentage of mothers of offspring with neural tube defects reported using an
opioid medication than mothers of offspring in the nonmalformed control group. They concluded
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that maternal periconception use of opioids increases the risk of neural tube defects more than
2-fold. The results may be confounded by recall bias though steps were taken to account for this.
The literature provided strong evidence for the underlying assumptions of this doctoral
project. Fetal opioid exposure can be catastrophic (Yazdy et al., 2013), Medicaid women are
prescribed opioids at higher rates than privately insured (Ailes et al., 2015), women are often
ambivalent about preventing pregnancy (W. Mosher et al., 2015), and conversations with an
APRN or other provider can be a cue for effective preconception care (C. Dehlendorf et al.,
2014).
Summary and Gaps
The basic assumption of this project is that fetal exposure to opioids is strongly correlated
with birth defects and this is supported by large, diverse, vigorous studies (Broussard et al.,
2011;Yazdy et al., 2013). There is also strong evidence that for women of reproductive age,
concurrent prescription of a category X medication (a strong teratogen) does not improve their
adherence to OCPs (Steinkellner, 2010). This is significant since the qualitative research
suggested that women are ambivalent about unplanned pregnancy (Askelson et al., 2015; W.
Mosher et al., 2015) and that providers often do not always engage women in shared decisionmaking regarding contraception (C. Dehlendorf et al., 2014).
The 18-44 age range of this DNP Project is supported by Ailes et al. (2015), Broussard et
al. (2011), Harper et al. (2015), W. Mosher et al. (2015), and Steinkellner (2010). Note that the
study about lowering pregnancy rates by training providers in LARC used the 18-25 age range
(Harper et al., 2015). The use of retrospective analysis for this kind of project is supported by
Ailes et al. (2015), Broussard et al. (2011), and Steinkellner (2010).
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The patient demographic at the CHC includes many low-income women who likely
have less than a high school education, have publicly funded insurance or no insurance, and are
for the most part white or Latina. The assumption that FQHC patients have health care disparities
is supported by the Ailes et al. (2015) study that revealed female Medicaid patients are
prescribed a disproportionately high rate of opioids. The assumption that women find preconception care acceptable has been elucidated and validated by the expanded health behavior
model. A study of female teens with type I diabetes reported that healthcare provider advice to
seek pre-conception care was a motivational cue that triggered action (Charron‐Prochownik et
al., 2001).
Further research was indicated, however, as the report from the CDC that gave us data on
prescription opioid rates defined women’s reproductive status by age rather than presence or
absence of LARC, surgical sterilization or menopause (Ailes et al., 2015). Since these variables
correlate with provider training and patient attitude towards health behaviors, more information
is needed to clarify the best interventions. This DNP Project also sought to validate the CHOICE
data showing that training health care providers in placement of long-acting contraception does
reduce pregnancy rates (Harper et al., 2015).

19
CHAPTER 3: METHODOLOGY
The problem addressed in this doctoral project was based on the CDC report that states
that too many women of reproductive age are receiving prescribed opioids (Ailes et al., 2015).
The research question is of women who are of reproductive age who are receiving prescription
opioids, what percentage have received effective preconception care in a community health
setting? In addition, whether provider training in LARC correlates with high LARC rates (Harper
et al., 2015).
Study Design
The research design for this DNP capstone project is a quantitative, descriptive, nonexperimental, retrospective analysis of existing data. The purpose of this project is to identify
what percentage of women of reproductive age who are receiving prescription opioids have
received effective preconception care in this setting.
Non-experimental design has been identified as being appropriate to describe a
phenomenon, especially when it would be unethical to manipulate the independent variable and
is commonly used for this kind of research (Ailes et al., 2015; Broussard et al., 2011;
Steinkellner, 2010). It also removes the need for informed consent since the data has already
been collected. Although several studies define reproductive age as beginning at 15 years of age
(Ailes et al., 2015; W. Mosher et al., 2015) or 16 years of age (Charron‐Prochownik et al., 2001),
because of the delicate nature of the topics and the need to protect the confidentiality of teens,
the age was raised to 18 at the request of the internal review board at Fresno State University.
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Definitions
“At risk” for pregnancy included no noted birth control method as well as less effective
birth control methods such as condoms or oral contraceptives. “Not at risk” included long acting
birth control, sterilization of patient or partner, menopause (surgical or physiologic). “Chronic
use of opioids” was defined as either the diagnosis on the patient’s problem list or two or more
refills of opioid prescriptions. “Acute use of opioids” was defined as one-time prescription of
opioids. If the provider listed as the primary care provider (PCP) had seen the patient twice or
less, the “PCP” was defined as either the provider who initiated the chronic opioid prescription
or the provider who had seen the patient the most in the four-year period. This was relevant since
the center had a three-year family medicine (physician) residency and a one year FNP residency
resulting in a high turn-over of providers. Providers were family nurse practitioners, physician
assistants, and physicians. “POPs” are progesterone only birth control pills.
Setting and Participants
Participants were a convenience sample from a community health center, seen between
2013 and 2016, female, between 18 to 45 years of age, with a diagnosis of chronic pain
syndrome or taking long acting opioids, and not pregnant. Exclusion criteria included genetic
males, being outside of the age range, lacking a diagnosis of chronic pain syndrome, not having
been seen between 2013 and 2016, and/or pregnant. It was hypothesized by the author that it
might be possible to predict preconception care by the presence or absence of LARC training
(contraceptive implant) of the patient’s PCP.
Procedures/Data Collection
The data (including demographics and PCP) was taken from information already
gathered in the electronic health records (EHR). The program was eClinicalWorks (ECW) and
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the data was exported to an Excel spreadsheet on the community health center’s servers which
were password protected and accessible only by current employees or contractors. Permission
was formally obtained from the community health center in the form of a letter from the Chief
Medical Officer. When first submitted to the university, the project proposal included minors.
Since teens are a protected population and the subjects of reproductive health and opioid use are
both sensitive, the internal review board declined to waive formal review of the project. After
revision, the doctoral project was approved on 08/18/2016 by the California State University at
Fresno committee for protection of human subjects.
The promise of EHR to provide fingertip access to population data took longer than
anticipated. Though in use for almost ten years at this CHC, obtaining data from the EHR in the
form of meaningful reports has only been possible in the last few years and takes a team of
people. Accurate information on reproductive status has been a struggle as there is no accurate
report available. Birth control method might be based on historical entries rather than current
data. Furthermore, menopause and permanent surgical sterilization are not structured, searchable
fields and required manual chart reviews by the primary author to determine actual reproductive
status for the project.
Search criteria for chronic pain syndrome, prescribed long acting opioids, and basic
demographics provided robust data. The variables of age, and insurance status were likely valid
and reliable, especially among the insured, since accuracy is needed for billing services. Race
was self-reported by the patient and recorded by the medical receptionist for all new patients.
The total data points drawn for the manual chart review were 145.
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Descriptive research was used to explore relationships between the variables.
Disproving the null hypothesis that all women of reproductive age are at risk for pregnancy
would disprove the assumption by Aimes et al (2015) that age correlates with risk of pregnancy.

23
CHAPTER 4: RESULTS
The CHC EMR search was for female patients seen between 2013 and 2016 with either a
diagnosis of chronic pain or prescriptions for opioids. The variables were age, ethnicity,
insurance type, primary care provider, and at risk or not for pregnancy.
The initial data drawn from the EMR had a sample size of 145 patients but a manual
chart review showed that only 48 were chronically prescribed opioids and the rest received a
one-time prescription for an acute visit. The acute visit patients were eliminated from the study.
There was an increase in visits over the four years of the study (Figure 2). Insurance type was
unfunded, Medicaid, Medicare, and private with only one patient with private insurance (See
Figure 3). The demographics showed female patients ranging from 23 to 44 years of age, 90%
Caucasian, 6% African American/Black, 4% Native American. Of the Caucasians, 28% were
Hispanic (Figure 4). Four patients were receiving prescribed opioids for both chronic pain and
addiction. PCPs had between one and four patients on the list and no one stood out as prescribing
significantly more than others.
The manual chart review for actual reproductive status showed that 43% of participants
had received effective preconception care (13% sterilized, 11% contraceptive implant, 17% IUD,
none menopause). The remaining participants had not received effective preconception care
(34% no method, 2% condom, 8% injection, 11% OCP, 2% POP). Two patients were actively
seeking pregnancy while receiving prescribed opioids (Figure 5). Ailes (2015) claimed all
women between 15 and 44 were at risk for pregnancy while this study found that in this setting
in women from 18-44, only a little more than half were at risk. We were unable to validate the
Ailes data regarding health disparities between Medicaid and private insurance since only one
patient had private insurance. However, the finding of significantly higher rates of opioid
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prescription among white women as compared to Hispanic women was validated. The LARC
question was not elucidated since practically all providers were trained in LARC and each
provider had so few patients.
Incidental findings and trends
Of the 90 acute visits in the original data set, 20 were the first and only visit for that
patient. Most, but not all, of the prescribers for these visits worked in the homeless shelter or
urgent care setting. Was this a function of the transient patient population of these settings or
were the patients going to multiple prescribers? These results are pertinent because the
community health center has a mandate to prevent diversion and misuse of opioids and a policy
to defer opioid prescription in the absence of prior medical records. Another finding among the
acute visits was that 17 prescriptions were from dentists. This is a reminder that opioid
prescribing is not limited to physicians, physician assistants, and nurse practitioners.
Conclusions
While the CDC defines all women of reproductive age as at risk for pregnancy, this study
found that almost half were not at risk due to sterilization, menopause, or effective birth control
(LARC). No providers were over-represented as prescribers of chronic opioid medications. Most
patients had Medicaid or no insurance and were predominantly white or Hispanic. LARC types
were almost equally divided between IUD, contraceptive implant, and sterilization.
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Figure 2. Female patient visits for chronically prescribed opioids.
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Figure 4. Race and ethnicity.
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CHAPTER 5: DISCUSSION AND RECOMMENDATIONS
While disproving the null hypothesis that all women of reproductive age are at risk for
pregnancy, the findings revealed there is still work to be done in the realm of preconception care
of women on prescribed opioids. More than half of the women with chronic opioid prescriptions
in the study had either no listed birth control or ineffective birth control. Given the catastrophic
outcomes of peri-conceptive fetal exposure to opioids, this is not acceptable. The data was
unable to validate the hypothesis that women on prescribed opioids are more likely to have
effective preconception care if their PCP was trained in LARC.
However, by industry standards, a LARC rate of 43% is not that low. It matches, within
one point, the Title X recommended goal for LARC utilization in a community health setting. he
In the CHC of this project, LARC utilization has been reported as only 13% but this possibly
speaks to the accuracy of the manual chart review.
Limitations of this study included reproducibility as it required a manual chart review.
Other health centers might lack the personnel hours to accomplish similar data acquisition.
Determination of the reproductive status of the patient was weighted towards “at risk” to increase
inter-rater reliability. If it was not immediately obvious from the problem list, medication list, or
history, a further chart review was not done by the reviewer. Results may be skewed by lack of
documentation and may have resulted in under-representation of menopause, abstinence, and
partner sterilization. The study was also limited by a small sample size. However, results are
likely generalizable to other CHCs with similar demographics of race and funding source.
The literature conclusively demonstrated that provider input is acceptable to patients
when making decisions about contraception and preconception care (C. Dehlendorf et al., 2014).
There may be special considerations for women receiving prescribed opioids which warrants
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further study. Research also revealed prescribers’ habits could be changed through audit and
feedback, working most effectively when the message is delivered by a peer, given more than
once, and has both measurable goals and a specific plan of action (Ivers et al., 2012). An
excellent next step would be development of a systems solution to the problem of preconception
care.
Next steps
Just as peers can influence prescriber practice, so can insurers. The region’s Medicaid
provider has been pressuring prescribers to lower the total dose of opioids for each of their
patients. In that same manner, could they pressure providers to prescribe only to women not at
risk for pregnancy? If at risk for pregnancy, specific, written patient consent would need to be
documented. The Chief Medical Officer of the CHC is on good terms with the medical director
of the Medicaid plan for the region and could provide guidance on this to the author.
For this CHC, focus could be made on Caucasian, non-Hispanic patients and those on
Medicaid since they made up most of the chronic pain patients. The CHC should continue
requiring contraceptive implant training for all prescribers, make reproductive status part of the
chronic pain template in a structured field. Enforce medical assistant rooming standards
requiring the notation of the birth control method of the patient. The chart review check list for
chronic pain should include the reproductive status and the chronic pain database should include
the variable of reproductive status.
This systematic documentation of the reproductive state should be spread to other chronic
diseases. Chronic pain syndrome is not the only disease state that commonly uses teratogenic
medications and hyperglycemia of diabetes can be teratogenic (Fountain et al., 2015; Yazdy et
al., 2013). Population management can help improve LARC rates and the author is already
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working with the EMR population management team on how to make reports on reproductive
status more accurate. The CHC already employs clinicians to clean up data sets for colon cancer
screening and other health maintenance so it would not be a stretch to add chronic pain syndrome
as it is not an overwhelming number of patients.
Conclusion
The landmark 2015 report from the Center for Disease Control posited that too many
women of reproductive age received prescribed opioids. This is significant because fetal
exposure to a known teratogen can have catastrophic outcomes. Furthermore, women are often
ambivalent about birth control and many pregnancies are unplanned. Fortunately, women
identify interactions with health care providers as acceptable cues for preconception decision
making. Data has shown that Medicaid populations are disproportionately prescribed opioids
compared to insured populations. However, the CDC defines reproductive status by age only.
Therefore, the purpose of this research project was to identify women’s actual risk for pregnancy
as defined by presence or absence of menopause, sterilization, or long-acting, reversible birth
control.
When putting research into practice, it is important to assess how the data fits the specific
patient population. In community health centers, rather than assuming all women of reproductive
age are at risk for pregnancy, a more nuanced approach can help focus resources. In this case,
population management to improve LARC rates overall and especially among the chronically ill
is the best recommendation.
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